ReviewCureus2022

Tumor Necrosis Factor-Alpha Inhibitors and Cardiovascular Risk in Rheumatoid Arthritis: A Systematic Review.

Shaalina Nair et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.